செய்து இல் இந்தியா தடுப்பூசி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from செய்து இல் இந்தியா தடுப்பூசி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In செய்து இல் இந்தியா தடுப்பூசி Today - Breaking & Trending Today

CISF to take over security of Bharat Biotech's campus in Hyderabad from June 14

NEW DELHI: The Central Industrial Security Force (CISF) will take over security of the Hyderabad campus of Bharat Biotech, the manufacturer of made-in-India Covid vaccine Covaxin, from June 14, official sources said. ....

Andhra Pradesh , North West Frontier , Ramdev Patanjali , Uttarakhand Haridwar , Central Industrial Security Force , Serum Institute Of India , Bharat Biotech , India Covid , Genome Valley , Inspector General , Chief Spokesperson Anil Pandey , Pune Based Serum Institute , Jewish Chabad , Navi Mumbai , Cisf Security , June 14 , Made In India Vaccine , Cisf To Take Over Security Of Bharat Biotechs Campus In Hyderabad From June 14 , ஆந்திரா பிரதேஷ் , வடக்கு மேற்கு எல்லை , ராமிதேவ் பதஞ்சலி , உத்தராகண்ட் ஹரித்வார் , மைய தொழில்துறை பாதுகாப்பு படை , சீரம் நிறுவனம் ஆஃப் இந்தியா , பாரத் பயோடெக் , மரபணு பள்ளத்தாக்கு ,

Second made-in-India COVID vaccine: Centre seals deal with Biological-E for 30 crore doses

Second made-in-India COVID vaccine: Centre seals deal with Biological-E for 30 crore doses
Times Now |
Embed
The health ministry has finalised arrangements with Hyderabad-based vaccine manufacturer Biological-E to book 30 crore COVID-19 vaccine doses, set to be manufactured and stockpiled from August to December this year. As per a health ministry statement on Thursday, an advance payment of Rs 1,500 crore will be made to Biological-E from the Centre. This is the second made-in-India vaccine after Bharat Biotech s COVAXIN. Biological-E s COVID-19 vaccine, an RBD protein sub-unit vaccine, is currently undergoing Phase-3 clinical trials. ....

Andhra Pradesh , Bharat Biotech , Health Ministry , Made In India Covid Vaccine , Made In India Vaccine , Made In India , Biological E , Covid Vaccine , ஆந்திரா பிரதேஷ் , பாரத் பயோடெக் , ஆரோக்கியம் அமைச்சகம் , செய்து இல் இந்தியா தடுப்பூசி , செய்து இல் இந்தியா , உயிரியல் ஏ ,

Centre Books 30 Crore Doses Of Biological E's Covid Vaccine Shot For Rs 1,500 Crore

Aiming at a stiff vaccination target, the government has booked 30 crore doses of Hyderabad-based Biological-E's Covid vaccine, which is still in clinical trials. ....

Serum Institute Of India Covishield , Centre Signs Deal To , National Expert Group On Vaccine Administration , Health Ministry , Department Of Biotechnology , Centre Signs Deal To Get , Made In India Vaccine , Doses Booked , Hyderabad Based Biological E , Bharat Biotech , Serum Institute , National Expert Group , Vaccine Administration , Biological E , Biologicale Vaccine , Biologicale Covid Vaccine , ஆரோக்கியம் அமைச்சகம் , துறை ஆஃப் உயிரி தொழில்நுட்பவியல் , செய்து இல் இந்தியா தடுப்பூசி , ஹைதராபாத் அடிப்படையிலானது உயிரியல் ஏ , பாரத் பயோடெக் , சீரம் நிறுவனம் , தேசிய நிபுணர் குழு , உயிரியல் ஏ ,

Ground News - India gov't seals deal for 300 mln Biological-E COVID-19 vaccine doses

India signs deal with domestic vaccine maker Biological-E for 300 million doses
BENGALURU (Reuters) -India s government said on Thursday it has inked a deal with domestic vaccine maker Biological-E for 300 million COVID-19 vaccine doses for 15 billion rupees ($205.62 million), the first such order for unapproved shots. Biological E., which also has a separate deal to produce about 600 million doses of Johnson & Johnson s COVID-19 shot annually, said on Tuesday it entered into a licensing agreement with Providence Therapeut…
12 hours ago|Los Angeles, United States ....

India General , Andhra Pradesh , United States , United Kingdom , New Delhi , Russian Federation , Los Angeles , Providence Therapeut , Union Ministry Of Health , Health Ministry , Ltd On , Centre Signs Deal To , Few Month As Centre Finalises Advance Deal , Few Month , Centre Finalises , Advance Deal , Union Ministry , Biologicale Ltd , Signs Deal To Get , Made In India Vaccine , Hyderabad Based Biological E , இந்தியா ஜநரல் , ஆந்திரா பிரதேஷ் , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , புதியது டெல்ஹி ,

India's vaccine diplomacy: Pak to receive India made Covid-19 vaccines under GAVI alliance

11:31 AM
Under it s vaccine maitri initiative, India has already sent Covid-19 vaccines to at least 65 countries
India will send at least 45 million vaccine doses to Pakistan as part of the Global Alliance for Vaccines and Immunisation, or GAVI. The vaccine agreed upon is Oxford-AstraZeneca’s Covishield vaccine that is manufactured by the Serum Institute of India. The first batch is scheduled to arrive in Pakistan in the middle of March.
All charges of the vaccine, from manufacture to delivery, have been waived off by GAVI as part of the initiative to provide free vaccines to poor countries. While the first batch of AstraZeneca’s Covishield vaccine is expected to land in Pakistan in mid-March, the remaining doses will arrive in waves within June. ....

Oxford Astrazeneca Covishield , Astrazeneca Covishield , Global Alliance For Vaccines , Serum Institute Of India , Global Alliance , Serum Institute , Chinese Made Cansino , Indias Vaccine Diplomacy , India Sends Vaccine To Pakistan , Pakistan Receives Indian Vaccines , Indian Vaccines , Indian Vaccine , Made In India , Made In India Vaccine , Corona Virus , Covid 19 , Coronavirus Vaccine , Covid 19 Vaccine , Indian Covid 19 Vaccine , Indian Coronavirus Vaccine , உலகளாவிய கூட்டணி க்கு தடுப்பு மருந்துகள் , சீரம் நிறுவனம் ஆஃப் இந்தியா , உலகளாவிய கூட்டணி , சீரம் நிறுவனம் , சீன செய்து கேன்சினோ , இந்தியச் தடுப்பூசி இராஜதந்திரம் ,